Long-term Outcomes of Transanal TME Show Low Recurrence Rates
Transanal total mesorectal excision (TATME) offers promising long-term oncologic outcomes for rectal cancer patients, with a low local recurrence rate of 4.55% at five years.
Newsletter
Every new paper in this field, in your inbox.
Transanal total mesorectal excision (TATME) offers promising long-term oncologic outcomes for rectal cancer patients, with a low local recurrence rate of 4.55% at five years.
Rural residency correlates with lower treatment rates and worse outcomes for colorectal liver metastases (CRLM).
Microscopically positive margins (R1) after colorectal liver metastasis resection indicate worse outcomes but require context for interpretation regarding recurrence and repeat surgeries.
The si-449 chondroitin sulfate adhesion barrier significantly decreases postoperative adhesion rates in open rectal resection patients, offering a promising option for improving surgical outcomes.
This systematic review reveals significant inconsistencies in cost reporting for robot-assisted colorectal surgery trials compared to laparoscopic approaches, with substantial implications for decision-making.
Complete resection of simultaneous hepatic and pulmonary metastases from metastatic colorectal cancer shows significant survival benefits and should be a key treatment goal for selected patients.
Using biological mesh for pelvic floor reconstruction after extralevator abdominoperineal resection in low rectal cancer patients does not provide a cost-effective solution despite slightly reducing perineal complications.
Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.
Curative surgery for locally recurrent rectal cancer (LRRC) is yielding better long-term outcomes, with a significant increase in the R0 resection rate and overall survival.
A nomogram can help predict early postoperative deep vein thrombosis (DVT) in gastric and colorectal cancer patients despite routine anticoagulant prophylaxis.